International Conference and Exhibition on Otolaryngology
International Conference and Exhibition on Otolaryngology was organized by OMICS Group on October 15-17, 2012 at DoubleTree by Hilton Chicago-Northshore, USA. Otolaryngology-2012 was graced by leading scientists across the globe.
Chicago, IL, October 21, 2012 --(PR.com)-- Otolaryngology’12
International Conference and Exhibition on Otolaryngology was organized by OMICS Group with a goal to provide a scientific forum for all stakeholders of Otolaryngology to enable the interactive exchange of knowledge held on October 15-17, 2012 at DoubleTree by Hilton Chicago-Northshore, USA Otolaryngology-2012 was graced by leading scientists across the globe. They gave presentations and discussed current advances in the research of otolaryngology.
Dr. Thomas Murry
Dr. Thomas Murry, Professor of Speech Pathology in Otolaryngology, Department of Otolaryngology, Weill Cornell Medical College gave his talk on Chronic cough: a laryngeal dysfunction. His talk highlighted the assessment of laryngeal function in patients with unresolved chronic cough despite being previously treated. The onset of chronic cough is often unknown and the number of treatments tried is often directed at problems of the nasopharynx or gastroenterological system. The larynx is often overlooked. Non-pulmonary chronic cough may be diagnosed in patients who complain of shortness of breath, choking, and voice disorders. When the larynx is examined, clinicians may observe a normal larynx, inflammation, and/or the presence of paradoxical vocal fold motion. The complaints by the patients may be attributed to clinical observations or they may range from dysphagia, post nasal drip or gastroesophageal reflux disease. Factors such as duration of the condition, timeline of which symptom actually came first, and cooccurrence of other conditions make the diagnosis and the treatment a challenge. These factors may include neurological changes, post nasal drip, upper respiratory infections or pulmonary disease. In most cases, the true cause of chronic cough is never identified. Moreover, without a definitive diagnosis, treatment often fails and the patient is left to seek other options or even just simply they live with it. In many cases, patients report partial resolution of the problem and stop seeking treatment. In others, medications help to diminish the problem and the patient is satisfied with partial resolution. All too often, these medications offer short term help but after a period of time the symptoms return.
Richard J. Wiet
Richard J. Wiem, Professor of Clinical Otolaryngology and Neurosurgery at Northwestern University and Senior Partner, Ear Institute of Chicago, LLC gave his talk on History and newer management strategies in acoustic neuroma management. Here is a bird’s view on his talk. Vesitbular schwannomas are the most common CPA tumor representing 6%-10% of intracranial neoplasm. Incidence is 10 per million per year in the US. NF2 represents about 5% of these CPA tumors. Among these cases 10% will present with normal hearing, and 90% will present with unilateral hearing loss and tinnitus. ABR is a noninvasive test for acoustic neuroma with a fairly high false potential rate. However, MRI is still the gold standard in diagnosis of tumors 2mm in size or larger. Three management strategies: observation, radiation, and surgery are the options for patients and each were discussed on the basis of management of more than 1500 cases seen over a thirty year period. He also focused his talk on recent conservative trends in management of the acoustic neuroma patient in the past decade.
Speakers:
1. Thomas Murry
2. Richard J. Wiet
3. Charles E. Bishop
4. David D Pothier
5. Quintin Pan
6. Steven J. Wang
7. Ivan H El-Sayed
8. Cathie Garnis
9. Marcos Paiva
10. Hesham AL-Mashad
11. Mariela C Torrente
12. Martin Rothenberg
13. Uttam K. Sinha
14. Jan Geliebter
15. Rainald Knecht
16. J.Bouguila
17. Larin Stiller-Timor
18. Yassin S. Bahgat
19. Robert I. Henkin
20. Kevin K. Ohlemiller
21. Kensei Naito
22. Mette Pedersen
23. Alexandre Minoru Enoki
24. A. Méndez Zorrilla
25. Begoña García Zapirain
26. Maria Evasovich
27. C. Alexander Ashford
28. Amr E. El-Shazly
29. Peter A. Tass
30. Nandini Manoli
31. Petra Wilder-Smith
32. Seiichi Nakata
33. Giuseppe Malafronte & Barbara Filosa
34. Feng Wang
35. Henrik Strom Roum
36. Mihan J Javid
37. Ahmed Mehanna
38. Hans Anderl
39. Yassin S. Bahgat
International Conference and Exhibition on Otolaryngology was organized by OMICS Group with a goal to provide a scientific forum for all stakeholders of Otolaryngology to enable the interactive exchange of knowledge held on October 15-17, 2012 at DoubleTree by Hilton Chicago-Northshore, USA Otolaryngology-2012 was graced by leading scientists across the globe. They gave presentations and discussed current advances in the research of otolaryngology.
Dr. Thomas Murry
Dr. Thomas Murry, Professor of Speech Pathology in Otolaryngology, Department of Otolaryngology, Weill Cornell Medical College gave his talk on Chronic cough: a laryngeal dysfunction. His talk highlighted the assessment of laryngeal function in patients with unresolved chronic cough despite being previously treated. The onset of chronic cough is often unknown and the number of treatments tried is often directed at problems of the nasopharynx or gastroenterological system. The larynx is often overlooked. Non-pulmonary chronic cough may be diagnosed in patients who complain of shortness of breath, choking, and voice disorders. When the larynx is examined, clinicians may observe a normal larynx, inflammation, and/or the presence of paradoxical vocal fold motion. The complaints by the patients may be attributed to clinical observations or they may range from dysphagia, post nasal drip or gastroesophageal reflux disease. Factors such as duration of the condition, timeline of which symptom actually came first, and cooccurrence of other conditions make the diagnosis and the treatment a challenge. These factors may include neurological changes, post nasal drip, upper respiratory infections or pulmonary disease. In most cases, the true cause of chronic cough is never identified. Moreover, without a definitive diagnosis, treatment often fails and the patient is left to seek other options or even just simply they live with it. In many cases, patients report partial resolution of the problem and stop seeking treatment. In others, medications help to diminish the problem and the patient is satisfied with partial resolution. All too often, these medications offer short term help but after a period of time the symptoms return.
Richard J. Wiet
Richard J. Wiem, Professor of Clinical Otolaryngology and Neurosurgery at Northwestern University and Senior Partner, Ear Institute of Chicago, LLC gave his talk on History and newer management strategies in acoustic neuroma management. Here is a bird’s view on his talk. Vesitbular schwannomas are the most common CPA tumor representing 6%-10% of intracranial neoplasm. Incidence is 10 per million per year in the US. NF2 represents about 5% of these CPA tumors. Among these cases 10% will present with normal hearing, and 90% will present with unilateral hearing loss and tinnitus. ABR is a noninvasive test for acoustic neuroma with a fairly high false potential rate. However, MRI is still the gold standard in diagnosis of tumors 2mm in size or larger. Three management strategies: observation, radiation, and surgery are the options for patients and each were discussed on the basis of management of more than 1500 cases seen over a thirty year period. He also focused his talk on recent conservative trends in management of the acoustic neuroma patient in the past decade.
Speakers:
1. Thomas Murry
2. Richard J. Wiet
3. Charles E. Bishop
4. David D Pothier
5. Quintin Pan
6. Steven J. Wang
7. Ivan H El-Sayed
8. Cathie Garnis
9. Marcos Paiva
10. Hesham AL-Mashad
11. Mariela C Torrente
12. Martin Rothenberg
13. Uttam K. Sinha
14. Jan Geliebter
15. Rainald Knecht
16. J.Bouguila
17. Larin Stiller-Timor
18. Yassin S. Bahgat
19. Robert I. Henkin
20. Kevin K. Ohlemiller
21. Kensei Naito
22. Mette Pedersen
23. Alexandre Minoru Enoki
24. A. Méndez Zorrilla
25. Begoña García Zapirain
26. Maria Evasovich
27. C. Alexander Ashford
28. Amr E. El-Shazly
29. Peter A. Tass
30. Nandini Manoli
31. Petra Wilder-Smith
32. Seiichi Nakata
33. Giuseppe Malafronte & Barbara Filosa
34. Feng Wang
35. Henrik Strom Roum
36. Mihan J Javid
37. Ahmed Mehanna
38. Hans Anderl
39. Yassin S. Bahgat
Contact
OMICS Group Inc
Bhargava Gopishetty
650-268-9744
omicsonline.org
Bhargava Gopishetty
650-268-9744
omicsonline.org
Contact
Categories